Airnov Healthcare Packaging Celebrates 5 Years of Manufacturing in India

Cuddalore facility continues to serve a growing demand in the Indian market and represents an important hub for future regional growth. The company will exhibit a broad range of healthcare packaging solutions, including HAT-B®, EQius®, laser marked canisters and DRICARD™ at CPHI India 2022.

Airnov Healthcare Packaging, a global leader in controlled atmosphere packaging, has surpassed five years of manufacturing at its production facility in India.

The plant, located in Cuddalore which sits south of Chennai in the Indian state of Tamil Nadu, is operated by a workforce of around 40 dedicated employees and is ISO 9001 and ISO 15378.

Beginning production in 2017, the Indian site is an important local hub for Airnov serving what is a growing national and regional market. It will also prove critical in meeting future growth in demand for Airnov’s healthcare packaging solutions.

Shrikar Trikannad, Head of sales India at Airnov, commented: “We continue to see great promise in the Indian market, which is proving very receptive to the pioneering products that we are able to bring to customers.”

“As we look ahead to the next five years, India will continue to play a key role in our business planning.”

The milestone arrives as Airnov exhibits at CPHI 2022 in India, a leading tradeshow connecting stakeholders in the pharmaceutical sector.

In particular, guests are invited to discover a range of products. These include:

  • HAT®-B: Airnov’s latest innovative vial, is designed to limit carbon footprints with an optimized amount of plastic. They contain an adjustable desiccant quantity and incorporate versatile sorbent materials to fit stability requirements. The vial, suitable for the pharmaceutical, diagnostic and nutraceutical markets, is available in two sizes and is compatible with existing filling lines.
  • EQius®: Airnov’s equilibrium relative humidity stabilizers are sorbent products that can maintain a specific required humidity level in pharmaceuticals. They are particularly designed to protect dry powder inhalers, gelatine capsules, and gummies. The development of Airnov’s EQius portfolio will help customers’ control relative humidity from 10% to 95%, and meet specific needs for the pharmaceutical and nutraceutical markets.
  • Laser marked canisters: These canisters use laser technology to create visible marks on the canister body without inks, varnishes, adhesives, and other extraneous materials for a more sustainable product with less risk of contamination. The portfolio will be complete this year with the release of 2g and 3g.
  • DRICARD: The new line of blue Dricard boasts double thickness, which allows for twice the moisture adsorption capacity across the same sized product. It also enables 80% less ink to be used, providing an important sustainability benefit.
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version